Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Oct 01, 2019 8:02am
164 Views
Post# 30181051

RE:RE:FAMOUS LAST WORDS

RE:RE:FAMOUS LAST WORDSI have a question to do with screening of patients .. is this done by a computer program or medical staff and if by staff wouldn't it be reasonably easy to write a program? 

Hankerchief wrote
toade1313 wrote: At the 2018 AGM I specifically asked Dr Jewett if ph2 would have problems getting patients to enroll like ph1 did. He basically stated that because Theralase now had much clearer definitions for inclusions and exclusions and with the many contacts Theralase had at PMH getting patients to enroll should be no problem.

Now almost a year and a half later, what is the biggest concern out there for Theralase? GETTING PATIENTS ENROLLED. 


Believe what they do, not what they say.  It's like listening to politicians or the FED.  You never know what will happen until it happens.............but when it happens, look outr!

Bullboard Posts